Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person1
PTC INC.
Company
Primary record20
PTC INC. filed 8-K
Item 2.02 Results of Operations and Financial Condition. On November 4, 2026, PTC Inc. announced results for its fourth quarter and fiscal year ended September 30, 2026. A copy of the press release is furnished herewith
PTC THERAPEUTICS, INC. filed 8-K
Item 7.01. Regulation FD Disclosure. On November 3, 2026, PTC Therapeutics, Inc. (the “Company”) issued a press release announcing that its Board of Directors (the “Board”) authorized a share repurchase program. The pres
PTC THERAPEUTICS, INC. filed 8-K
Item 2.02. Results of Operations and Financial Condition. On October 29, 2026, PTC Therapeutics, Inc. (the “Company”) announced its financial results for the quarter ended September 30, 2026. The full text of the press r
PTC INC. filed 4
SEC form 4 filed by PTC INC. (CIK 857005) on 2026-10-16.
PTC THERAPEUTICS, INC. filed 4
SEC form 4 filed by PTC THERAPEUTICS, INC. (CIK 1070081) on 2026-10-16.
PTC THERAPEUTICS, INC. filed 4
SEC form 4 filed by PTC THERAPEUTICS, INC. (CIK 1070081) on 2026-10-13.
PTC THERAPEUTICS, INC. filed 4
SEC form 4 filed by PTC THERAPEUTICS, INC. (CIK 1070081) on 2026-10-09.
PTC THERAPEUTICS, INC. filed 4
SEC form 4 filed by PTC THERAPEUTICS, INC. (CIK 1070081) on 2026-10-07.
PTC INC. filed 4
SEC form 4 filed by PTC INC. (CIK 857005) on 2026-10-06.
PTC INC. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. Agreement and Plan of Merger On October 4, 2026, PTC Inc., a Massachusetts corporation (the Company ), entered into an Agreement and Plan of Merger (the Merger Agreem
PTC THERAPEUTICS, INC. filed 4
SEC form 4 filed by PTC THERAPEUTICS, INC. (CIK 1070081) on 2026-10-02.
SANGAMO THERAPEUTICS, INC filed 8-K
Item 1.03 Bankruptcy or Receivership. The information set forth under Item 2.01 below is incorporated into this Item 1.03 by reference. Item 2.01 Completion of Acquisition or Disposition of Assets. As previously disclose
PTC THERAPEUTICS, INC. filed 8-K
Item 7.01. Regulation FD Disclosure. On September 21, 2026, PTC Therapeutics, Inc. (the Company ) issued a press release announcing that it completed the previously announced agreement with Sangamo Therapeutics, Inc. ( S
PTC THERAPEUTICS, INC. filed 4
SEC form 4 filed by PTC THERAPEUTICS, INC. (CIK 1070081) on 2026-09-18.
PTC INC. filed 4
SEC form 4 filed by PTC INC. (CIK 857005) on 2026-09-17.
PTC THERAPEUTICS, INC. filed 4
SEC form 4 filed by PTC THERAPEUTICS, INC. (CIK 1070081) on 2026-09-11.
PTC THERAPEUTICS, INC. filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. On August 25, 2026, PTC Therapeutics, Inc. (the “Company”) entered into an asset purchase agreement (the “Asset Purchase Agreement”) with Sangamo Therapeutics, Inc.
PTC THERAPEUTICS, INC. filed 4
SEC form 4 filed by PTC THERAPEUTICS, INC. (CIK 1070081) on 2026-08-28.
SANGAMO THERAPEUTICS, INC filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. The information set forth below in Item 1.03 of this Current Report on Form 8-K under the heading “PTC Asset Purchase Agreement” is incorporated herein by reference.
PTC THERAPEUTICS, INC. filed 4
SEC form 4 filed by PTC THERAPEUTICS, INC. (CIK 1070081) on 2026-08-21.